DEINOVE
ALDEI | XPAR
Overview
Corporate Details
- ISIN(s):
- FR0010879056 (+1 more)
- LEI:
- 969500BEJSRFER0F2K08
- Country:
- France
- Address:
- 1682 RUE DE LA VALSIERE, 34790 GRABELS
- Website:
- https://www.deinove.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: the “microbial dark matter”. By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance. The new therapies discovered and developed by DEINOVE target superbugs (microbes that have become resistant to one or more antimicrobials) that cause life-threatening infections which are now spreading at high speed.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2023-01-24 17:45 |
Inside Information Statement
Conversion de la procédure de redressement judiciaire en liquidation judiciaire
|
French | 80.4 KB | |
| 2023-01-24 17:45 |
Inside Information Statement
Conversion of the receivership proceedings into judicial liquidation proceedings
|
English | 67.6 KB | |
| 2023-01-16 19:09 |
Inside Information Statement
DEINOVE - Point sur la procédure de redressement judiciaire
|
French | 79.4 KB | |
| 2023-01-16 19:09 |
Inside Information Statement
DEINOVE - Update on the receivership proceedings
|
English | 66.5 KB | |
| 2022-12-16 18:10 |
Inside Information Statement
DEINOVE - Point sur la Procédure de Redressement Judiciaire
|
French | 80.2 KB | |
| 2022-12-16 18:10 |
Inside Information Statement
DEINOVE - Update on the Receivership Proceedings
|
English | 67.5 KB | |
| 2022-11-07 17:45 |
Inside Information Statement
Deinove annonce L’ouverture d’une procédure de redressement judiciaire
|
French | 72.0 KB | |
| 2022-11-07 17:45 |
Inside Information Statement
Deinove Announces the Opening of Receivership Proceedings
|
English | 89.5 KB | |
| 2022-10-28 17:51 |
Inside Information Statement
DEINOVE REQUESTS RECEIVERSHIP PROCEEDINGS
|
English | 67.6 KB | |
| 2022-10-28 17:51 |
Inside Information Statement
DEINOVE SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE
|
French | 68.6 KB | |
| 2022-10-20 17:45 |
Inside Information Statement
DEINOVE - Adoption of the resolutions at the Shareholders’ Extraordinary Genera…
|
English | 69.8 KB | |
| 2022-10-20 17:45 |
Inside Information Statement
DEINOVE - Adoption de l'ensemble des résolutions de son Assemblée Générale Extr…
|
French | 71.2 KB | |
| 2022-10-10 17:45 |
AGM Report
DEINOVE - Extraordinary General Meeting of October 17, 2022: Appointment of an …
|
English | 86.3 KB | |
| 2022-10-10 17:45 |
AGM Report
DEINOVE- Assemblée générale extraordinaire du 17 octobre 2022 : Désignation d'u…
|
French | 88.2 KB | |
| 2022-10-06 19:02 |
Inside Information Statement
DEINOVE présente ses résultats financiers et l’avancée de ses programmes pour l…
|
French | 239.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |